Global private equity investor Advent International, and specialty chemicals company LANXESS are establishing a joint venture have formed a joint-venture to acquire engineering materials business (DEM) from Dutch group Royal DSM.
The Enterprise Value is around €3.7 billion and will be financed by the joint venture via equity from Advent and external debt. The business represents sales of around EUR1.5 billion with an EBITDA margin of approximately 20%.
In addition, LANXESS is combining its High Performance Materials (HPM) business unit with DEM.
Read more: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.